BSX Boston Scientific Corp

Price (delayed)

$44.46

Market cap

$63.3B

P/E Ratio

120.16

Dividend/share

N/A

EPS

$0.37

Enterprise value

$69.74B

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, ...

Highlights
Boston Scientific's gross profit has increased by 14% QoQ and by 8% YoY
The revenue has increased by 11% from the previous quarter and by 10% YoY
The EPS has soared by 164% from the previous quarter but it has plunged by 87% YoY
Boston Scientific's net income has surged by 135% QoQ but it has shrunk by 85% YoY
The P/E is 13% above the 5-year quarterly average of 106.5

Key stats

What are the main financial stats of BSX
Market
Shares outstanding
1.42B
Market cap
$63.3B
Enterprise value
$69.74B
Valuations
Price to earnings (P/E)
120.16
Price to book (P/B)
3.96
Price to sales (P/S)
5.64
EV/EBIT
77.23
EV/EBITDA
27.27
EV/Sales
6.23
Earnings
Revenue
$11.2B
EBIT
$903M
EBITDA
$2.56B
Free cash flow
$1.95B
Per share
EPS
$0.37
Free cash flow per share
$1.37
Book value per share
$11.22
Revenue per share
$7.88
TBVPS
$10.21
Balance sheet
Total assets
$31.17B
Total liabilities
$15.23B
Debt
$9.11B
Equity
$15.94B
Working capital
$2.69B
Liquidity
Debt to equity
0.57
Current ratio
1.66
Quick ratio
1.07
Net debt/EBITDA
2.52
Margins
EBITDA margin
22.8%
Gross margin
66.9%
Net margin
5.2%
Operating margin
4.2%
Efficiency
Return on assets
1.7%
Return on equity
3.4%
Return on invested capital
5.1%
Return on capital employed
3.3%
Return on sales
8.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BSX stock price

How has the Boston Scientific stock price performed over time
Intraday
-0.54%
1 week
1.88%
1 month
-0.76%
1 year
19.07%
YTD
23.67%
QTD
3.98%

Financial performance

How have Boston Scientific's revenue and profit performed over time
Revenue
$11.2B
Gross profit
$7.49B
Operating income
$469M
Net income
$582M
Gross margin
66.9%
Net margin
5.2%
BSX's operating margin has surged by 200% since the previous quarter but it is down by 36% year-on-year
Boston Scientific's net income has surged by 135% QoQ but it has shrunk by 85% YoY
Boston Scientific's net margin has surged by 117% QoQ but it has shrunk by 87% YoY
Boston Scientific's operating income has decreased by 30% YoY

Growth

What is Boston Scientific's growth rate over time

Valuation

What is Boston Scientific stock price valuation
P/E
120.16
P/B
3.96
P/S
5.64
EV/EBIT
77.23
EV/EBITDA
27.27
EV/Sales
6.23
The EPS has soared by 164% from the previous quarter but it has plunged by 87% YoY
The P/E is 13% above the 5-year quarterly average of 106.5
The stock's price to book (P/B) is 17% less than its 5-year quarterly average of 4.8 but 14% more than its last 4 quarters average of 3.5
The equity has grown by 2.1% YoY
BSX's P/S is 18% above its 5-year quarterly average of 4.8 and 5% above its last 4 quarters average of 5.4
The revenue has increased by 11% from the previous quarter and by 10% YoY

Efficiency

How efficient is Boston Scientific business performance
The return on equity has surged by 162% since the previous quarter but it has dropped by 89% year-on-year
The return on assets has surged by 143% since the previous quarter but it has dropped by 87% year-on-year
BSX's ROIC has soared by 132% YoY and by 59% from the previous quarter
The ROS has soared by 119% YoY and by 42% from the previous quarter

Dividends

What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSX.

Financial health

How did Boston Scientific financials performed over time
Boston Scientific's total assets is 105% more than its total liabilities
BSX's current ratio is down by 11% year-on-year and by 8% since the previous quarter
BSX's quick ratio is up by 4.9% year-on-year
Boston Scientific's debt is 43% lower than its equity
Boston Scientific's debt to equity has decreased by 7% YoY
Boston Scientific's debt has decreased by 4.4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.